Decreasing Risk of Psychosis by Sulforaphane: Study Protocol for a study (DROPS study)
This study is active but not recruiting in China. It is testing sulforaphane for Clinical High Risk Syndrome of Psychosis.
SchizophreniaBehavioralFrom 15 Years to 45 Years
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Then choose your country and confirm availability with each study site.
In plain English
Key information made simple
What is this study testing?
This study is testing whether Sulforaphane may be useful for people experiencing schizophrenia.
What would participation involve?
Participants may complete study activities around Sulforaphane, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in China.
Who is it mainly for?
This study appears to be mainly for people with schizophrenia.
What should you check before joining?
Ask about whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.
Your next step
Check the study details
Check the official source, then confirm these points with the research team.
Where are visits, can any be remote, and how much time is needed?
Costs and support
What costs, reimbursement or compensation apply?
Before joining
Questions to ask before joining
What are the exact eligibility criteria, and what could exclude someone?
How many visits, assessments, or follow-ups are expected, and over what period?
What risks, side effects, practical burdens, or alternatives should be understood first?
Who should be contacted to confirm locations, timing, compensation, and next steps?
Study clarity
Things to check before joining
Study start dateStarted: July 14, 2019
Recruitment status
Active Not Recruiting
Enrollment listed in the registry
300
Sponsor
Shanghai Jiao Tong University School of Medicine
Sponsor type
University
Study type
Behavioral
Intervention type
COMBINATION_PRODUCT, DIETARY_SUPPLEMENT
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
China
Age range
From 15 Years to 45 Years
Official registry ID
NCT03932136
Official title
Decreasing Risk of Psychosis by Sulforaphane: Study Protocol for a Randomized, Double-blind, Placebo-controlled, Clinical Multicenter Trial (DROPS Trial)
Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: NCT03932136. We help you review the study, but cannot decide medical eligibility.
Check recruitment and locations
Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.
The overall study status can differ from each site's status. Open a country to see its locations and their registry status.
China · 9 sites
Guangzhou Psychiatric Hospital
Guangzhou, Guangdong
Site status: Not listed — confirm with the team
the First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan
Site status: Not listed — confirm with the team
Second Xiangya Hospital of Central South University
Changsha, Hunan
Site status: Not listed — confirm with the team
Suzhou Psychiatric Hospital
Suzhou, Jiangsu
Site status: Not listed — confirm with the team
Shanghai Mental Health Center
Shanghai, Shanghai Municipality
Site status: Not listed — confirm with the team
Shanghai Xuhui District Mental Health Center
Shanghai, Shanghai Municipality
Site status: Not listed — confirm with the team
Shanghai Pudong Nanhui Mental Health Center
Shanghai, Shanghai Municipality
Site status: Not listed — confirm with the team
Shenzhen Kangning Hospital
Shenzhen, Shenzhen
Site status: Not listed — confirm with the team
Tianjin Anding Hospital
Tianjin, Tianjin Municipality
Site status: Not listed — confirm with the team
In practice
For you
Participation may contribute to research. Personal benefit is not guaranteed.
Ask the research team to explain the activities, time commitment, and follow-up involved.
Study sites are listed. Confirm the relevant site and any travel before making plans.
Important
Not medical advice
Information from public sources.
Are you the study sponsor? Contact us to update this page: hi@hopestage.com
FAQ
Questions about this study
What is this study trying to understand?
This study is exploring psychotherapy or therapy for people with schizophrenia. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
What is a behavioral study?
This appears to be a behavioral / psychological / psychosocial study involving Sulforaphane, Placebo. Phase 3 studies are usually larger and aim to confirm effectiveness and safety in a broader group.
Who might this study be for?
This study may concern people with schizophrenia; age range: From 15 Years to 45 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
What would I likely need to do?
You may take part in sessions or exercises related to habits, thoughts, emotions, or behaviors. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
Could this study affect my mood, habits, motivation, or stress?
Behavioral studies can involve habits, emotions, motivation, stress, sleep, or ways of thinking. Ask whether the intervention could affect your mood or stress, and who to contact if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by Shanghai Jiao Tong University School of Medicine, which appears to be a university. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Explore other studies
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
